scholarly journals De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era

Hepatology ◽  
2018 ◽  
Vol 68 (4) ◽  
pp. 1288-1297 ◽  
Author(s):  
Allison J. Kwong ◽  
W. Ray Kim ◽  
Jennifer A. Flemming
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplant ◽  
De Novo ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

scholarly journals De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents

2018 ◽  
Vol 5 (1) ◽  
pp. HEP06 ◽  
Author(s):  
Gabriela Kuftinec ◽  
Thomas Loehfelm ◽  
Michael Corwin ◽  
Blythe Durbin-Johnson ◽  
MarieChristi Candido ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
De Novo ◽  
Antiviral Agents ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents ◽  
De Novo Hepatocellular Carcinoma

The risk of de novo hepatocellular carcinoma still exists in the in the direct acting antiviral era

2018 ◽  
Vol 3 ◽  
pp. 100-100
Author(s):  
Stephen H. Gray ◽  
Mohamed G. Shoreibah ◽  
Jayme E. Locke ◽  
Jared A. White
Keyword(s):  
Hepatocellular Carcinoma ◽  
De Novo ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals

2020 ◽  
Vol 73 ◽  
pp. S208-S209
Author(s):  
Elisabetta Degasperi ◽  
Enrico Galmozzi ◽  
Serena Pelusi ◽  
Roberta D’ambrosio ◽  
Roberta Soffredini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
Risk Score ◽  
Genetic Risk ◽  
De Novo ◽  
Genetic Risk Score ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document